Rhythm Pharmaceuticals Inc RYTM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/28/24 EDT
44.00quote price arrow up+0.67 (+1.55%)
Volume
73,907
Close
43.33UNCH (UNCH)
Volume
798,659
52 week range
15.50 - 52.57
Loading...
  • Open42.54
  • Day High43.66
  • Day Low41.79
  • Prev Close41.79
  • 52 Week High52.57
  • 52 Week High Date02/12/24
  • 52 Week Low15.50
  • 52 Week Low Date07/06/23

Key Stats

  • Market Cap2.606B
  • Shares Out60.14M
  • 10 Day Average Volume0.67M
  • Dividend-
  • Dividend Yield-
  • Beta1.89
  • YTD % Change-5.74

KEY STATS

  • Open42.54
  • Day High43.66
  • Day Low41.79
  • Prev Close41.79
  • 52 Week High52.57
  • 52 Week High Date02/12/24
  • 52 Week Low15.50
  • 52 Week Low Date07/06/23
  • Market Cap2.606B
  • Shares Out60.14M
  • 10 Day Average Volume0.67M
  • Dividend-
  • Dividend Yield-
  • Beta1.89
  • YTD % Change-5.74

RATIOS/PROFITABILITY

  • EPS (TTM)-3.21
  • P/E (TTM)-13.52
  • Fwd P/E (NTM)-10.45
  • EBITDA (TTM)-182.599M
  • ROE (TTM)-85.10%
  • Revenue (TTM)77.428M
  • Gross Margin (TTM)87.99%
  • Net Margin (TTM)-238.52%
  • Debt To Equity (MRQ)62.53%

EVENTS

  • Earnings Date04/30/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Rhythm Pharmaceuticals Inc

Related Video

Hennion & Walsh’s Kevin Mahn on his top stock picks: CRWD, MSFT, LLY, RYTM
VIDEO3:0903:09
Hennion & Walsh’s Kevin Mahn on his top stock picks: CRWD, MSFT, LLY, RYTM

Profile

MORE
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE, as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. IMCIVREE is approved by the Food and Drug Administration (FDA) for chronic weight management in adult and pediatric patients six years of age and older with monogenic or...
David Meeker M.D.
Chairman of the Board, President, Chief Executive Officer
Hunter Smith
Chief Financial Officer, Treasurer
Yann Mazabraud
Executive Vice President, Head of International
Jennifer Chien
Executive Vice President, Head of North America
Address
222 Berkeley Street, 12th Floor Boston
Boston, MA
02116
United States

Top Peers

SYMBOLLASTCHG%CHG
KYMR
Kymera Therapeutics Inc
40.20UNCHUNCH
RXRX
Recursion Pharmaceuticals Inc
9.97UNCHUNCH
ALPN
Alpine Immune Sciences Inc
39.64UNCHUNCH
NTLA
Intellia Therapeutics Inc
27.51UNCHUNCH
RCKT
Rocket Pharmaceuticals Inc
26.94UNCHUNCH